Pricing

Shinobi Therapeutics

0 followers

‌

Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.

Industries

Biotechnology, Life Sciences

Headquarters

South San Francisco, US

Employees

11-50

Links

Org chart

Dan Kemp

Chief Executive Officer

Dan Kemp

Collapse

Bhanu Iyer

VP US Operations & HR

Ryosuke Gonotsubo

Chief Of Staff

Teams

This company has no teams yet

Similar companies

Capricor Therapeutics

1 follower

Elicio Therapeutics

1 follower

Artiva Biotherapeutics

1 follower

Thermo Fisher Scientific

159 followers

Roivant Sciences

56 followers

10X Genomics

13 followers

Pfizer

471 followers

Neurocrine Biosciences

5 followers

KBI Biopharma

5 followers

Coherus BioSciences

5 followers

Moderna Therapeutics

104 followers

Explore companies